Stay updated on MODEL Clinical Trial: Lifestyle Modification & Liraglutide
Sign up to get notified when there's something new on the MODEL Clinical Trial: Lifestyle Modification & Liraglutide page.

Latest updates to the MODEL Clinical Trial: Lifestyle Modification & Liraglutide page
- Check7 days agoChange DetectedThe web page has been updated to version 2.15.2, indicating a new revision, while the previous version 2.15.0 has been removed. Additionally, a section with helpful links from the University of Pennsylvania Center for Weight and Eating Disorders has been deleted.SummaryDifference0.4%
- Check14 days agoNo Change Detected
- Check22 days agoChange DetectedThe webpage has undergone significant updates, including the introduction of a 12-week extension study for participants taking liraglutide, with a focus on the use of phentermine as a treatment option. Key details about the study's design, eligibility criteria, and collaboration with Novo Nordisk A/S have been added.SummaryDifference41%
- Check29 days agoChange DetectedThe web page has been updated from version 2.14.3 to version 2.14.4.SummaryDifference0.0%
- Check36 days agoNo Change Detected
- Check72 days agoChange DetectedThe page has removed a notice regarding heavy traffic affecting the performance and availability of some NLM-NCBI services and products.SummaryDifference0.8%
- Check87 days agoChange DetectedThe web page now includes a notice about heavy traffic affecting the performance and availability of some NLM-NCBI services and products, along with contact information for assistance.SummaryDifference0.8%
- Check94 days agoChange DetectedThe website has been updated from version v2.14.1 to v2.14.2.SummaryDifference0.0%
Stay in the know with updates to MODEL Clinical Trial: Lifestyle Modification & Liraglutide
Enter your email address, and we'll notify you when there's something new on the MODEL Clinical Trial: Lifestyle Modification & Liraglutide page.